The European Commission is establishing a Scientific Panel of Independent Experts to support the implementation and enforcement of the AI Act — a key framework
EUCAIM is pleased to announce the signing of two important Memoranda of Understanding (MoUs) with the QUANTUM project and the European Society of Paediatric Radiology
A new editorial in European Radiology outlines how the EUCAIM repository is transforming cancer imaging research, and what it means for authors publishing in ESR journals. The
https://www.youtube.com/watch?v=7foZdKsrJOY Download the presentation slides. Webinar Q&A: Question Answer Will this initiative collaborate with HE-Cluster Health for the 2 calls on GenAI (in case
The EIC Work Programme 2025 is here, and with it comes a groundbreaking funding opportunity for researchers and innovators in AI-driven cancer diagnostics! The EIC
We are thrilled to share the success of EUCAIM’s participation at the European Congress of Radiology 2025! This year’s congress was a fantastic opportunity to
We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.
Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.
Apply by 10 June 2024!
We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.
EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.
Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.
Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.